<code id='CF9DA6A985'></code><style id='CF9DA6A985'></style>
    • <acronym id='CF9DA6A985'></acronym>
      <center id='CF9DA6A985'><center id='CF9DA6A985'><tfoot id='CF9DA6A985'></tfoot></center><abbr id='CF9DA6A985'><dir id='CF9DA6A985'><tfoot id='CF9DA6A985'></tfoot><noframes id='CF9DA6A985'>

    • <optgroup id='CF9DA6A985'><strike id='CF9DA6A985'><sup id='CF9DA6A985'></sup></strike><code id='CF9DA6A985'></code></optgroup>
        1. <b id='CF9DA6A985'><label id='CF9DA6A985'><select id='CF9DA6A985'><dt id='CF9DA6A985'><span id='CF9DA6A985'></span></dt></select></label></b><u id='CF9DA6A985'></u>
          <i id='CF9DA6A985'><strike id='CF9DA6A985'><tt id='CF9DA6A985'><pre id='CF9DA6A985'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:414
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          FDA approves first new drug developed for postpartum depression
          FDA approves first new drug developed for postpartum depression

          AdobeTheFoodandDrugAdministrationonTuesdayapprovedbrexanolone,thefirstdrugspecificallytargetedtotrea

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          How AI can help patients find reliable information about doctors

          AdobeAlmostassoonasChatGPTwasreleasedtothepublic,doctorsbeganfocusingonhowtheycouldharnessartificial